SGLT2 inhibitors - a breakthrough in treatment of heart failure and their multipotential beneficial role in cardiology, diabetology, nephrology and neurology

• Auteurs principaux: Marta Bogowska (Auteur), Aleksandra Berner (Auteur), Klaudia Marczyk (Auteur), Karolina Matyja (Auteur), Anna Olszewska (Auteur), Maciej Pękała (Auteur), Paulina Polak (Auteur), Monika Polaszek (Auteur), Karina Stelmaszak (Auteur), Katarzyna Stencel (Auteur)
• Format: Livre
• Publié: Kazimierz Wielki University, 2023-10-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Inhibitors of the sodium-glucose cotransporter 2 (SGLT2 inhibitors) are relatively new and innovative antihyperglycemic drugs which by inhibiting sodium-glucose cotransporter 2 minimalise reabsorption of glucose in nephrones. Due to this process, SGLT2 inhibitors became a first-choice drugs in diabe...